Research & Development

Research & Development is essential in all industries. And, when it comes to the Biopharmaceutical research industry, R&D services not only generates income for the companies involved in the research but it often brings results in lives being saved, or at least enhancement in patient's lives. The development for many companies requires the perfect Pharmaceutical research & development. There has been a great deal of research and development in this industry by the doctors and scientists all over the world. Reliable Pharmaceutical R&D services allow companies to follow manufacturing procedures, quality control measures being taken, production scope and technical know-how.

Stem Cell and Gene Delivery

An update

These days gene and stem cell therapies have the potential to make the substantial impact on the treatment of several diseases However there are pros and cons of each strategy but the optimal selection of gene delivery vector or stem cell may often lead to better therapeutic effect..

Reaching a New Innovation Threshold

How can we make it happen?

This article talks about how the difficulty of getting reimbursement in the US and Europe for novel therapeutics especially ones based on innovative new technology platforms renders such products less available in AsiaPacific as well since twothirds of NASs are developed in the US and Europe A numbe..

Merging Technology Transfer with Knowledge Translation

Academic to industrial research

Technology transfer is not just limited to industries and RD A research scientist working in RD may also work with universities There are several examples of patent or product commercialisation happening in universities This article focuses on how technology transfer can be coupled with knowledge tr..

Creating The Perfect Capsule

Choosing the right shell excipient for your formulation challenges

This article outlines the key challenges facing soft and hard capsule formulation and focuses on the importance of choosing the right excipient to optimise the delivery of Active Pharmaceutical Ingredients APIs It also explains why gelatin is the excipient of choice for pharmaceutical manufacturers ..

Knowing vs Hunting for Targets

Selecting a target for settingup the drug discovery path is a tough decision and often this choice is based on borrowed and incomplete knowledge from the literature In many cases this has led to serious challenges in the late stages of clinical trials dealing with patients In most cases these drug d..

Single-Use Method Using Filter Aid Easy Removal of Midstream Cells

Discussing midstream as the gapfilling technology between up and downstream and alluvial filtration as the solution for efficient cell removal in just one step this article shows how efficiency in cell removal is increased in a singleuse format which also allows for easy scaleup..

Emerging Directions in R&D of Drug Discovery and Development

The patient specificity paradigm

Delivering patient relevant healthcare and patient centric drug discovery and innovation based approach globally is the new and emerging requirement It means the very starting material knowledge and data is to be connected with the patient and only patient Conventional methods relying on extrapolati..

Mass Spectrometry in Research and Development of Protein Biologics

The soft ionisation revolution in mass spectrometry took place in last decade of 20th century After that mass spectrometry quickly rose to prominence in the life science laboratories The paradigm of the pharmaceutical RD has also changed over the same time and biological drugsgenerally called big mo..

Changing the Game in Drug Development

Modelling & Simulation

To improve the Return on Investment ROI for drug development the biopharmaceutical industry has investedin methods technologies and operational programs to reduce cost and improve efficiency Modelling and simulation lives at the intersection of biology and technology It is used to reliably and predi..

Reviving Pharma R&D Productivity with New Modalities

The pharmaceutical industry is facing a decline in RD productivity However genomics biomarkers and access to human tissue samples are offering a range of well validated but challenging biological targets To seize the opportunity leveraging New Modalities and abolishing silos is a must and represent ..

TOP